Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Valeant Pharmaceuticals Intl Inc    VRX   CA91911K1021

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Valeant Pharmaceuticals Intl : Health Care Higher As Paulson Joins Valeant Board - Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/19/2017 | 10:31pm CEST

Shares of health-care companies rose as one big investor endorsed one of the hardest hit companies during the recent retreat from the sector. Hedge-fund billionaire John Paulson joined the board of Valeant Pharmaceuticals International, a sign that the investor remains bullish on the drugmaker's prospects despite the rout in Valeant's shares over the last year. The specialty drugmaker came under pressure after allegations of accounting improprieties and lost the support of some big institutional holders, such as William Ackman's Pershing Square. Medical-test maker PerkinElmer said it would buy a German medical-diagnostics company Euroimmun Medical Laboratory Diagnostics for $1.3 billion, expanding its reach into autoimmune and allergy testing.

-Rob Curran, [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VALEANT PHARMACEUTICALS IN
06/23 OPTIONS TRADE ALERT : InvestorsObserver releases covered-call reports for Alibab..
06/22 VALEANT PHARMACEUTICALS INTL : Bausch + Lomb Named Most Trusted Contact Lens Sol..
06/21 VALEANT PHARMACEUTICALS INTL : Bausch + Lomb Invites Surgeons to 'Test Drive' Ne..
06/20DJVALEANT PHARMACEUTICALS INTL : Paulson Joins Valeant's Board -- WSJ
06/20 VALEANT PHARMACEUTICALS INTL : Appoints Arthur J. Shannon As Senior Vice Preside..
06/20 VALEANT PHARMACEUTICALS INTL : Appoints Arthur J. Shannon As Senior Vice Preside..
06/19DJVALEANT PHARMACEUTICALS INTL : Health Care Higher As Paulson Joins Valeant Board..
06/19 VALEANT PHARMACEUTICALS INTERNATIONA : Change in Directors or Principal Officers..
06/19 VALEANT PHARMACEUTICALS INTL : Billionaire Paulson joins Valeant Pharmaceuticals..
06/19 JOHN PAULSON : Billionaire investor Paulson joins Valeant board, shares jump
More news
Sector news : Pharmaceuticals - NEC
06/23DJSAMSUNG ELECTRONICS : Makes Play for Drug Market With Version of Humira -- Updat..
06/23DJSAMSUNG ELECTRONICS : Makes Big Play in Drug Market With Cheaper Version of Bloc..
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/23 China's ICBC says checks of loans to big acquirers are routine
06/22 GSK'S NEW CEO AIMS TO DIVEST SPORTS : sources
More sector news : Pharmaceuticals - NEC
Advertisement
Financials ($)
Sales 2017 8 757 M
EBIT 2017 3 287 M
Net income 2017 -349 M
Debt 2017 25 910 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 3,57x
EV / Sales 2018 3,36x
Capitalization 5 383 M
More Financials
Chart VALEANT PHARMACEUTICALS IN
Duration : Period :
Valeant Pharmaceuticals In Technical Analysis Chart | VRX | CA91911K1021 | 4-Traders
Full-screen chart
Technical analysis trends VALEANT PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 18
Average target price 15,4 $
Spread / Average Target -2,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive VP-Finance
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert Alexander Ingram Director
Robert N. Power Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VALEANT PHARMACEUTICAL..8.82%5 383
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results